Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
clinical trials
new york
new york blog main
new york top stories
san francisco blog main
akcea therapeutics
alnylam pharmaceuticals
amgen
anylam pharmaceuticals
beijing
biotech
brii bio
brii biosciences
cardiomyopathy
china
cholesterol
data
deals
drugs
glaxosmithkline
gsk
hepatitis b
inclisiran
inotersen
ldl
mark timney
mt sinai hospital
neuropathy
onpattro
patisiran
pcsk9
peter wijngaard
pfizer
praluent
prashant vaishnava
What
drug
medicines
3
×
year
3
×
disease
aces
adds
ago
akcea
alliance
alnylam
amyloidosis
announced
approved
areas
attr
available
battle
big
biosciences
bio’s
brii
ceo
cholesterol
debilitating
earlier
fda
flexible
genetic
hepatitis
inclisiran
infectious
key
launched
lowering
meant
medco
medicine
million
mission
nasdaq
Language
unset
Current search:
medicines
×
year
×
" national top stories "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline